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1. Introduction 
Like immunotherapy, chemotherapy, and surgery, radiotherapy is one of the major tools in 
fighting against cancer. As acute IR is applied, cell can trigger its self-defensive mechanisms 
in response to genome stresses [1]. As one of the pivotal anticancer genes within the cell, P53 
can control the transcription and translation of series genes, and trigger cell cycle arrest and 
apoptosis through interaction with downstream genes and their complicated signal 
pathways [2]. Under radiotherapy, the outcomes of cellular response depend on the 
presence of functional P53 proteins to induce tumor regression through apoptotic pathways 
[3]. Conversely, the P53 tumor suppressor is the most commonly known specific target of 
mutation in tumorigenesis [4]. Abnormalities in the P53 have been identified in over 60% of 
human cancers and the status of P53 within tumor cells has been proposed to be one of the 
determinant response to anticancer therapies [3,4]. Controlled radiotherapy studies show 
the existence of a strong biologic basis for considering P53 status as a radiation predictor 
[3,5]. Therefore, the status of P53 in tumor cell can be considered as a predictor for long-term 
biochemical control during and after radiotherapy [6-8].  
Recently, several models have been proposed to explain the damped oscillations of P53 in 
cell populations [9-12]. However, the dynamic mechanism of the single-cell responses is not 
completely clear yet, and the complicated regulations among genes and their signal 
pathways need to be further addressed, particularly under the condition of acute IR.  
Many studies have indicated that introducing novel mathematical and computational 
approaches can stimulate in-depth investigation into various complicated biological systems 
(see, e.g., [13-23]). These methods have provided useful tools for both basic research and 
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drug development [24-33], helping understanding many marvelous action mechanisms in 
various biomacromolecular systems (see, e.g., [21,34-39]).  
Based on the existing models [9-12] and inspired by the aforementioned mathematical and 
computational approaches in studying biological systems, here a new model is proposed for 
studying the P53 stress response networks under radiotherapy at the cellular level, along 
with the kinetics of DNA double-strand breaks (DSBs) generation and repair, ATM and ARF 
activation, as well as the regulating oscillations of P53-MDM2 feedback loop (MDM2 is an 
important negative regulator of the p53 tumor suppressor). Furthermore, the kinetics of the 
oncogenes degradation, as well as the eliminations of the mutation of P53 (mP53) and the 
toxins were presented. Also, the plausible outcomes of cellular response were analyzed 
under different IR dose domains.  
It is instructive to mention that using differential equations and graphic approaches to study 
various dynamical and kinetic processes of biological systems can provide useful insights, 
as indicated by many previous studies on a series of important biological topics, such as 
enzyme-catalyzed reactions [18,40], low-frequency internal motions of biomacromolecules 
[41-46], protein folding kinetics [47,48], analysis of codon usage [49,50], base distribution in 
the anti-sense strands [51], hepatitis B viral infections [52], HBV virus gene missense 
mutation [53], GPCR type prediction [54], protein subcellular location prediction [55], and 
visual analysis of SARS-CoV [56,57].  
In the present study, we are to use differential equations and directed graphic approaches to 
investigate the dynamic and kinetic processes of the cellular responding radiotherapy.  
2. Method 
2.1. Model review 
Under the genome stresses, many efforts have been made to enhance P53-mediated 
transcription through some models [58,59] [9-12]. However, the interactions in a real system 
would make these models [60] extremely complicated. Therefore, a new feasible model is 
needed in order to incorporate more biochemical information. To realize this, let us take the 
following criteria or assumptions for the new model: (1) only the vital components and 
interactions are taken into account; (2) all the localization issues are ignored; (3) the simple 
linear relations are used to describe the interactions among the components concerned; and 
(4) there are enough substances to keep the system ‘‘workable’’ [58].  
The new integrated model thus established for the P53 stress response networks under 
radiotherapy is illustrated in Fig.1. Compared with the previous models [9-12], the current 
model contains more vital components, such as oncogenes, ARF and mP53, as well as their 
related regulating pathways. In the DSBs generation and repair module, the acute IR 
induces DSBs stochastically and forms DSB-protein complexes (DSBCs) at each of the 
damage sites after interacting with the DNA repair proteins [2,3]. As a sensor of genome 
stress, ATM is activated by the DSBCs signal transferred from DSBs. Meanwhile, the over-
expression of oncogenes prompted by acute IR can trigger the activation of ARF, further 
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prompting the ATM activation [2] [7]. The cooperating effects of active ATM (ATM*) and 
active ARF (ARF*) switch on or off the P53-MDM2 feedback loop [2] [7,9], further regulating 
the downstream genes to control the cell cycle arrest and the cell apoptosis in response to 
genome stresses [8]. Here, we use the superscript * to represent the activate state as done in 
[61]. 
 
Figure 1. Illustration showing the integrated model of P53 stress response networks under 
radiotherapy. It is composed of three modules, including DNA damage generation and repair, ATM 
and ARF activation, as well as P53-MDM2 feedback loop. As acute IR is applied, ARF is activated by the 
over-expression of oncogenes, and ATM is activated with the cooperation of DSBCs and ARF*. ATM* 
and ARF* corporately trigger the responding mechanism of P53-MDM2 feedback loop. 
2.2. DSBs generation and repair 
Under the continuous effect of acute IR dose, DSBs occur and trigger two major repair 
mechanisms in eukaryotic cells: homologous recombination (HR) and nonhomologous end 
joining (NHEJ) [62,63]. About 60-80% of DSBs are rejoined quickly, whereas the remaining 
20-40% of DSBs are rejoined more slowly [64,65]. As shown in Fig.2, the module of DSBs 
generation and repair process contains both the fast and slow kinetics, with each being 
composed of a reversible binding of repair proteins and DSB lesions into DSBCs, and an 
irreversible process from the DSBCs to the fixed DSBs [62,65]. DSBCs are synthesized by 
binding the resulting DSBs with repair proteins (RP), which is the main signal source to 
transfer the DNA damage to P53-MDM2 feedback loop by ATM activation [2].  
Due to the misrepair part of DSBs (Fw) having the profound consequences on the subsequent 
cellular viability and the cellular response in fighting against genome stresses [1,3], we 
obviously distinguish between correct repair part of DSBs (Fr) and Fw [9,10,12]. Moreover, 
we further deal the total Fw in both repair processes as a part of toxins within the cell 
[2,4,11], which can be eliminated by the regulatory functions of P53 during and after 
radiotherapy, and treated as an indicator of outcomes in cellular response to genome 
stresses [2]. 
Some experimental data suggest that the quantity of the resulting DSBs within different IR 
dose domains obey a Poisson distribution [11]. In accordance with the experiments, we 
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Figure 2. Illustration showing the module of DNA repair process. It includes both a fast repair pathway 
and a slow one. DSB can be in one of four states: intact DSB (DSB), DBSC, Fr and Fw. Subscripts ‘1’ and 
‘2’ refer to the fast kinetics and slow one. 
assume that the stochastic number of the resulting DSBs per time scale is proportional to the 
number generated by a Poisson random function during the period of acute radiation [11]. 
The DSBs generation process is formulated as follows: 
 
[DT]
Poissrnd( IR)
t ir
d
k a
dt
    (1) 
where [DT] is the concentration of total resulting DSBs induced by IR in both fast and slow 
repair processes. kt is the parameter to set the number of DSBs per time scale, and air is the 
parameter to set the number of DSBs per IR dose.  
Moreover, we assume that the limited repair proteins are available around DSBs sites, and 
70% of the initial DSBs are fixed by the fast repair process. Each DSB can be in one of the 
four states: intact DSB, DSBC, Fr and Fw  [9,10,12]. Thus, we have the following differential 
equations: 
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where [D], [C], and [Fw] represent the concentrations of DSBs, DSBCs, and Fw in the fast and 
the slow repair kinetics respectively, kdc, kcd, kcf, and kfw are the transition rates among the 
above three states; kdc, and kcross represent the first-order and second-order rate constants in 
both the fast and the slow repair kinetics respectively [65]. Srp is the basal induction rate of 
repair mRNA, and subscripts ‘1’ and ‘2’ refer to the fast and the slow kinetics.  
2.3. ATM and ARF activation 
As a DNA damage detector, ATM exists as a dimer in unstressed cells. After IR is applied, 
intermolecular autophosphorylation occurs, causing the dimer to dissociate rapidly into the 
active monomers. The active ATM monomer (ATM*) can prompt the P53 expression further 
[64]. Meanwhile, ARF, another tumor suppressor, is activated by hyperproliferative signals 
emanating from oncogenes, such as Ras, c-myc etc., further prompting the ATM activation 
[2,7,10]. Based on the existing model of ATM switch [11], we present an ATM and ARF 
activation module under IR. Shown in Fig.3 is the module scheme of ATM and ARF 
activation, which includes five components: ATM dimer, inactive ATM monomer, ATM*, 
ARF, and ARF*. Compared with the previous studies in [9-12], ARF, oncogenes, and the 
related signal pathways are involved in this module [2,7. Here, let us assume that DSBCs is 
the main signal transduction from DSBs to P53-MDM2 feedback loop through ATM 
activation, and the rate of ATM activation is a function of the amount of DSBCs, ARF* and 
the self-feedback of ATM*. Furthermore, the total concentration of ATM is a constant, 
including ATM dimer, ATM monomer and ATM, as treated in {Ma, 2005 #1194]. 
 
Figure 3. Illustration showing the module scheme of ATM and ARF activation under constant IR. ARF 
is activated by the over-expression of oncogenes induced by acute IR, and ATM is activated from ATM 
monomers under the cooperating effects of DSBCs, ARF*, and self-feedback of ATM*. 
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As a detector of DNA damage, ATM activation plays an important role in triggering the 
regulatory mechanisms of P53 stress response networks [2,65]. After the acute IR is applied, 
phosphorylation of inactive ATM monomers is promoted first by DSBCs and then rapidly 
by means of the positive feedback from ATM*, accounting for the intermolecular 
autophosphorylation [11]. Meanwhile, under the circumstance of continuous IR dose, ARF, 
a detector of over-expression of oncogenes is activated by hyperproliferative signals 
emanating from oncogenes, further prompting the ATM activation [2,7,10], as can be 
formulated as follows: 
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where [ATMd], [ATM] and [ATM*] represent the concentrations of ATM dimer, ATM 
monomer, and active ATM monomer respectively; [Onco], [ARF] and [ARF*] represent the 
concentrations of oncogenes, ARF, and active ARF respectively; kundim,  kdim,  kar, and kaf  are 
the rates of ATM undimerization, ATM dimerization, ATM monomer inactivation, and 
ATM monomer activation, respectively. Sarf, konf, kad and kpad are the rates of ARF basal 
induction, ARF activation triggered by Oncogenes, ARF degradation, and ARF* 
degradation, respetively. In addition, f is the function of ATM activation, the term a1C 
implies the fact that DSBs somehow activate ATM molecules at a distance, a2[ATM*] 
indicates the mechanism of autophosphorylation of ATM, a3C[ATM*] represents the 
interaction between the DSBCs and ATM* [9-12,66], and a4[ARF*] represents the regulating 
function of ARF* to ATM activation [1,3,7].  
2.4. Regulation of P53-MDM2 feedback loop  
As shown in Fig.4, P53 and its principal antagonist, MDM2 transactivated by P53, form a 
P53-MDM2 feedback loop, which is the core part in the integrated networks [9-12]. ATM* 
elevates the transcriptional activity of P53 by prompting phosphorylation of P53 and 
degradation of MDM2 protein [67]. Also, ARF* can indirectly prompt the transcriptional 
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activity of P53 by inhibiting the expression of MDM2 and preventing P53 degradation 
[2,7,9]. With the cooperating regulations of ATM* and ARF*, this negative feedback loop can 
produce oscillations in response to the sufficiently strong IR dose [11].  
 
Figure 4. The directed graph of P53-MDM2 feedback loop under radiotherapy. P53 is translated from 
P53mRNA and phosphorylated by ATM* and ARF*. MDM2 protein promotes a fast degradation of P53 
protein and a slow degradation of P53*. In addition, ATM*and ARF* stimulate the degradation of 
MDM2, and then indirectly increase the regulatory activation of P53* further. Especially, oncogenes, 
toxins and mP53 are decreased directly by the regulatory functions of P53*. 
Especially, the mutation of P53 (mP53) triggered by oncogenes is added in this module, and 
mP53 is further dealt as another detector of outcomes in cellular response to acute IR. To 
account for a decreased binding affinity between inactive P53 and P53*, we assume that 
MDM2-induced degradation of inactive P53 is faster than that of P53*, and only P53* can 
induce target genes to depress the over-expression of oncogenes and further eliminate the 
toxins within the cell [3,4,9-12]. The main differential equations used in this module are as 
follows: 
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where [P53R], [P53P], [P53*], [MDM2R], and [MDM2P] represent the concentrations of P53 
mRNA, P53 protein, active P53, MDM2 mRNA, and MDM2 protein, respectively; [Onco], 
[Toxins], and [mP53] represent the concentrations of oncogenes, Fw  and mP53, respectively. 
SP53, and SMDM2 represent the basal induction rates of P53 mRNA and MDM2 mRNA, 
respectively; k, and d represent the regulation and degradation rates among genes and 
proteins, respectively. The other parameters are presented in Tables 1-3. 
 
Parameters Description Constant 
kt Rate of DSBs generation per time scale 0.01 
air Number of DSBs generation per IR dose 35 
a1 Percentage of DSs processed by fast repair 0.70 
a2 Percentage of DSs processed by slow repair 0.30 
kdc1 Rate of DSBs transition to DSBCs in fast repair process 2 
kdc2 Rate of DSBs transition to DSBCs in slow repair process 0.2 
kdc1 Rate of DSBCs transition to DSBs in fast repair process 0.5 
kdc2 Rate of DSBCs transition to DSBs in slow repair process 0.05 
kfd1 Rate of DSCs transition to Fd in fast repair process 0.001 
kfd2 Rate of DSCs transition to Fd in slow repair process 0.0001 
kcross Rate of DSB binary mismatch in second order repair process 0.001 
Table 1. The parameters used in the DSBs generation and repair processes 
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Parameters Description Constant 
kdim ATM dimerization rate 8 
kundim ATM undimerization rate 1 
kaf ATM phosphorylation rate 1 
kar ATM dephosphorylation rate 3 
Sarf Basal induction rate of ARF mRNA 0.001 
konf ARF activation rate triggered by Oncogenes 0.06 
kad ARF  degradation rate 0.015 
kpad ARF* degradation rate 0.01 
a1 Scale of the activation function of ATM phosphorylation 1 
a2 Scale of the activation function of ATM phosphorylation 0.08 
a3 Scale of the activation function of ATM phosphorylation 0.8 
Table 2. The parameters used in the process of ATM and ARF activation 
 
Parameters Description Constant 
SP53 Basal induction rate of P53 mRNA  0.001 
drp Degradation rate of P53 mRNA 0.02 
krp Translation rate of P53 mRNA 0.12 
kp*p Dephosphorylation rate of P53* 0.2 
kapp* ATM*-dependent phosphorylation rate of P53 0.6 
kmp MDM2-dependent degradation rate of P53 0.1 
kmp* MDM2-dependent degradation rate of P53* 0.02 
dpp Basal degradation rate of P53 0.02 
dpp* Basal degradation rate of P53* 0.008 
SMDM2 Basal induction rate of MDM2 mRNA 0.002 
kp*m P53-dependent MDM2 transcription rate 0.03 
kmrp Translation rate of MDM2 mRNA 0.02 
dmr Degradation rate of MDM2 mRNA 0.01 
dmp Basal degradation rate of MDM2 0.003 
kmat ATM*-dependent degradation rate of MDM2 0.01 
kmar ARF*-dependent degradation rate of MDM2 0.02 
kp Michaelis constant of ATM*-dependent P53 phosphorylation 1.0 
k Michaelis constant of P53-dependent MDM2 transcription 1.0 
kd Threshold concentration for MDM2-dependent P53 degradation 0.03 
n Hill coefficient of MDM2 transcription rate 4 
kat Threshold concentration for ATM*-dependent MDM2 degradation 1.60 
kar Threshold concentration for ARF*-dependent MDM2 degradation 1.10 
kd* Threshold concentration for MDM2-dependent P53* degradation 0.32 
konIR Activation rate of oncogenes induced by IR 0.002 
konp Degredation rate of oncogenes induced by P53* 0.006 
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Parameters Description Constant 
ktfw Toxins accumulation rate triggered by IR 0.6 
kpt Toxins elimination rate triggered by P53* 0.1 
kmpo Induction rate of mP53 induced by oncogenes over-expression 0.03 
kmpd Elimination rate of mP53 triggered by P53* 0.015 
Table 3. The parameters used in the process of P53-MDM2 loop and toxins degradation 
3. Results and discussion 
To ensure the accuracy of the simulation results, we consider that the valid parameter sets 
should obey the following rules [2,11,67]. (1) The model must contain oscillations because 
there has been experimental evidence that oscillations occur between P53 and MDM2 after 
cell stress. (2) The mechanism used to mathematically describe the degradation of P53 by 
MDM2 is accurate only for low concentrations of P53. (3) The concentration of P53* is much 
higher than that of inactive P53 after the system reaching an equilibrium.  
Based on the above three rules and the existing parameter sets used in [11], we obtained the 
kinetics of P53 stress response networks and cellular response under acute IR dose through 
simulation platform in MATLAB7.0. The detailed parameters used for the current model are 
given in Tables 1-3. 
3.1. Kinetics of DSBCs synthesizing  
During the simulation process, the continuous 2, 5, and 7Gy IR are applied into a cell 
respectively. As shown in Fig.5a, owing to the condition that many DSBs occur and the 
limited RP are available around damage sites, the concentration of RP begins to decrease as 
IR dose overtakes 5Gy, and trends to zero versus radiation time. Meanwhile, the kinetics of 
DSBCs synthesizing is shown in Fig.5b. We can see that the rates of DSBCs synthesis keep 
increasing under 2, and 5Gy IR, whereas, it begins to decrease and trend to constant after 
about 120min under 7Gy IR dose.  
3.2. Kinetics of ARF and ATM activation  
The ARF activation is used to describe the mechanisms in cellular response to the over-
expression of oncogenes induced by acute IR [2,7]. The kinetics of ARF activation is shown 
in Fig.6a. Owing to the over-expression of oncogenes without depressing functions of P53*, 
ARF is activated fast and ARF* keeps increasing followed by trending to dynamic 
equilibrium versus radiation time. 
Meanwhile, the ATM activation module was established to describe the switch-like 
dynamics of the ATM activation in response to DSBCs increasing, and the regulation 
mechanisms during the process of the ATM transferring DNA damage signals to the P53-
MDM2 feedback loop. Under the cooperative function of DSBCs, ARF*, and the positive 
self-feedback of ATM*, the ATM would reach the equilibrium state within minutes due to  
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Figure 5. The kinetics of DSBs repairing and transferring under continuous effect of 2, 5, 7Gy IR.  
(a) The dynamics of RP available around the resulting DSBs under different IR dose domains.  
(b) The kinetics of DSBCs synthesized by DSBs and RP versus continuous radiation time under different 
IR dose domains.   
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Figure 6. The kinetics of ARF and ATM activation under 2, 5, 7Gy IR. (a) The kinetics of ARF activation 
in response to over-expression of oncogenes induced by different IR dose. (b) The switch-like kinetics of 
ATM activation, ATM* reach saturation and trend to constant state in response to continuous radiation 
time of different IR dose domains. 
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the fast phosphorylation [2,11,67]. Kinetics of ATM activation is shown in Fig.6b. ATM is 
activated rapidly and switches to “on” state with respective rates, and then trends to the 
saturation state. The step-like traces suggest that the ATM module can produce an on-off 
switching signal, and transfer the damage signal to the P53-MDM2 feedback loop [3]. 
Furthermore, under the cooperation effects of ATM* and ARF*, DNA damage signals can be 
further transferred to the downstream genes and their signal pathways more efficiently 
[2,7]. 
3.3. Outcomes of cellular responding radiotherapy 
The P53-MDM2 feedback loop is a vital part in controlling the downstream genes and 
regulation pathways to fight against the genome stresses [6,67,68]. In response to the input 
signal of ATM* and ARF*, the P53-MDM2 module generates one or more oscillations. The 
response traces of P53 and MDM2 protein under continuous application of 2, 5, and 7Gy IR 
from time 0 are shown in Fig. 7a. Upon the activation by ATM*, ARF* and decreased 
degradation by MDM2, the total amount of P53 proteins increases quickly. Due to the P53-
dependent induction of MDM2 transcription, the increase of MDM2 proteins is sufficiently 
large to lower the P53 level, which in turn reduces the amount of the MDM2 proteins.  
The oscillation pulses shown in Fig.7a have a period of 400 min, and the phase difference 
between P53 and MDM2 is about 100 min. Moreover, the first pulse is slightly higher than 
the second, quite consistent with the experimental observations [2,7,11] as well as the 
previous simulation results [9,10,12,69].  
Also, by comparing these simulation results, we can see that the strength and swing of these 
oscillations begin to decrease as IR overtakes 7Gy, suggesting that the ability of cellular 
responding genome stresses begin to decrease as IR dose exceeds a certain threshold. 
Furthermore, because in the current model the toxins, mP53 and oncogenes can be degraded 
directly by P53* in this module, we can plot the predictable outcomes of cellular response in 
fighting against genome stresses under different IR dose domains. As shown in Fig.7b, Fw 
remaining within the cell keeps decreasing with respective rate, and trends to zero versus 
continuous radiation time under 2 and 5Gy IR. Whereas, when IR exceeds 7Gy, Fw  begins to 
increase slightly with some oscillations. Also, the kinetics of oncogenes degrading is plotted 
in Fig.7c. As we can see, owing to the negative regulations of P53*, the expression level of 
oncogenes keeps decreasing after the first climate under 2 and 5Gy IR dose, and then begins 
to increase slowly under 7Gy IR dose. Meanwhile, as shown in Fig.7d, quite similar to the 
results in Fig.7b and Fig.7c, mP53 keeps decrease after reaching the first maximum under 2 
and 5Gy IR dose, and then begins to increase slowly under 7Gy IR dose. All these results 
obtained by the above simulations based on the new model indicate that that P53* indeed 
acts an important role in regulating downstream genes and their signal pathways, whereas 
its capabilities in cellular responding DNA damage under radiotherapy begin to decrease as 
the strength of IR exceeds a certain maximal threshold. 
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Figure 7. The outcomes of cellular responding 2, 5, 7Gy IR under radiotherapy. (a) The oscillating 
kinetics of P53* and MDM2 in response to the cooperative effect of ATM* and ARF* under different IR 
dose domains. (b) The kinetics of toxins elimination triggered by the functions of P53*. (c) The 
depressing dynamics of oncogenes over-expression with the regulations of P53*. (d) The kinetics of 
mP53 elimination triggered by the effect of P53*. 
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4. Conclusion 
A new model was proposed to simulate the P53 stress response network under 
radiotherapy. It is demonstrated according to our model that ATM and ARF exhibits a 
strong sensitivity and switch-like behavior in response to the number of DSBs, fully 
consistent with the experimental observations. Interestingly, it is shown in this study that 
after the DNA damage signals transferring, P53-MDM2 feedback loop will produce 
oscillations, then triggering the cellular self-defense mechanisms to degrade the toxins 
remaining within the cell, such as Fw, oncogenes, and mP53. Particularly, under different IR 
dose domains, the new model can reasonably predict outcomes of cellular response in 
fighting against genome stresses, and hence providing a framework for analyzing the 
complicated regulations of P53 stress response networks, as well as the mechanisms of the 
cellular self-defense under radiotherapy.  
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